Glioblastoma Multiforme Market Poised to Reach USD 4.5 Billion by 2031, Driven by R&D Surge and Rising Disease Burden in the US and Japan
The Global Glioblastoma Multiforme (GBM) Market reached USD 2.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 4.5 billion by 2031. The market is expected to exhibit a compound annual growth rate (CAGR) of 8.6% during...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek